Literature DB >> 25522986

HDL biogenesis, remodeling, and catabolism.

Vassilis I Zannis1, Panagiotis Fotakis, Georgios Koukos, Dimitris Kardassis, Christian Ehnholm, Matti Jauhiainen, Angeliki Chroni.   

Abstract

In this chapter, we review how HDL is generated, remodeled, and catabolized in plasma. We describe key features of the proteins that participate in these processes, emphasizing how mutations in apolipoprotein A-I (apoA-I) and the other proteins affect HDL metabolism. The biogenesis of HDL initially requires functional interaction of apoA-I with the ATP-binding cassette transporter A1 (ABCA1) and subsequently interactions of the lipidated apoA-I forms with lecithin/cholesterol acyltransferase (LCAT). Mutations in these proteins either prevent or impair the formation and possibly the functionality of HDL. Remodeling and catabolism of HDL is the result of interactions of HDL with cell receptors and other membrane and plasma proteins including hepatic lipase (HL), endothelial lipase (EL), phospholipid transfer protein (PLTP), cholesteryl ester transfer protein (CETP), apolipoprotein M (apoM), scavenger receptor class B type I (SR-BI), ATP-binding cassette transporter G1 (ABCG1), the F1 subunit of ATPase (Ecto F1-ATPase), and the cubulin/megalin receptor. Similarly to apoA-I, apolipoprotein E and apolipoprotein A-IV were shown to form discrete HDL particles containing these apolipoproteins which may have important but still unexplored functions. Furthermore, several plasma proteins were found associated with HDL and may modulate its biological functions. The effect of these proteins on the functionality of HDL is the topic of ongoing research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25522986     DOI: 10.1007/978-3-319-09665-0_2

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  32 in total

1.  Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis.

Authors:  Javier Gutierrez-Achury; Maria Magdalena Zorro; Isis Ricaño-Ponce; Daria V Zhernakova; Dorothée Diogo; Soumya Raychaudhuri; Lude Franke; Gosia Trynka; Cisca Wijmenga; Alexandra Zhernakova
Journal:  Hum Mol Genet       Date:  2015-11-05       Impact factor: 6.150

Review 2.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

3.  Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-I.

Authors:  Stefan Bibow; Yevhen Polyhach; Cédric Eichmann; Celestine N Chi; Julia Kowal; Stefan Albiez; Robert A McLeod; Henning Stahlberg; Gunnar Jeschke; Peter Güntert; Roland Riek
Journal:  Nat Struct Mol Biol       Date:  2016-12-26       Impact factor: 15.369

4.  Structure-function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk.

Authors:  Christina Gkolfinopoulou; Faye Soukou; Ioannis Dafnis; Tahsin F Kellici; Despina Sanoudou; Thomas Mavromoustakos; Efstratios Stratikos; Angeliki Chroni
Journal:  Cell Mol Life Sci       Date:  2020-07-14       Impact factor: 9.261

5.  Green fluorescent protein-tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress.

Authors:  Constantin N Takacs; Ursula Andreo; Rachel L Belote; Joan Pulupa; Margaret A Scull; Caroline E Gleason; Charles M Rice; Sanford M Simon
Journal:  Traffic       Date:  2017-01-31       Impact factor: 6.215

6.  High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

Authors:  Mariko Tani; Katalin V Horvath; Benoit Lamarche; Patrick Couture; John R Burnett; Ernst J Schaefer; Bela F Asztalos
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

Review 7.  ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

8.  Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b.

Authors:  Constantin N Takacs; Ursula Andreo; Viet Loan Dao Thi; Xianfang Wu; Caroline E Gleason; Michelle S Itano; Gabriella S Spitz-Becker; Rachel L Belote; Brenna R Hedin; Margaret A Scull; Charles M Rice; Sanford M Simon
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

9.  Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.

Authors:  Ilenia Minicocci; Anna Tikka; Eleonora Poggiogalle; Jari Metso; Anna Montali; Fabrizio Ceci; Giancarlo Labbadia; Mario Fontana; Alessia Di Costanzo; Marianna Maranghi; Aldo Rosano; Christian Ehnholm; Lorenzo Maria Donini; Matti Jauhiainen; Marcello Arca
Journal:  J Lipid Res       Date:  2016-04-03       Impact factor: 5.922

10.  The C-565T Polymorphism (rs2422493) of the ATP-binding Cassette Transporter A1 Gene Contributes to the Development and Severity of Coronary Artery Disease in an Iranian Population.

Authors:  Khalil Mahmoodi; Koorosh Kamali; Habib Ghaznavi; Mohammad Soleiman Soltanpour
Journal:  Oman Med J       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.